:max_bytes(150000):strip_icc()/GettyImages-2095975132-1c079bfff64b430192c32eaf0a5b3ac7.jpg?w=1920&resize=1920,1267&ssl=1 "BioNTech Stock Drops as Sales Outlook Disappoints | Global News Avenue")
BioNTech Stock Drops as Sales Outlook Disappoints
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2095975132-1c079bfff64b430192c32eaf0a5b3ac7.jpg)
Key Points
- Biontech’s U.S. listed stock fell on Monday, with the Covid-19 vaccine maker’s soft sales outlook shifting higher than expected quarterly.
- The German company said it expects total revenue in 2025 between 1.7 billion euros ($1.8 billion) and 2.2 billion euros ($2.4 billion), lower than visible Alpha analyst forecasts.
- Despite a tough start to 2025, the stock has grown by about 9% over the past 12 months.
Biontech’s US listed stocks (fighting) failed on Monday, which was a softer outlook for the year for Covid-19 vaccine manufacturers, offsetting the more than expected quarter.
The German company said it expects total revenue in 2025 between 1.7 billion euros ($1.8 billion) and 2.2 billion euros ($2.4 billion). That’s lower than its 2.8 billion euro revenue released in 2024, lagging behind the 2.4 billion euro consensus forecast for analysts by Alpha.
Biontech reports fourth quarter Earnings per share (EPS) Revenue was 1.08 euros of 1.2 billion euros, down from 1.88 euros per share of 1.5 billion euros a year ago, but ahead of schedule in analysts’ estimates.
Biontech attributes revenue decline to its partner PfizerPFE). Biontech said writing will continue to impact its annual outlook.
Biontech stock fell about 3% to $105.28 on Monday. Although it’s a tough start to 2025, they have earned about 9% over the past 12 months.
Correction – March 10, 2025: This article has been corrected since its first publication to reflect the euro to reflect income.
:max_bytes(150000):strip_icc()/GettyImages-2095975132-1c079bfff64b430192c32eaf0a5b3ac7.jpg?w=1200&resize=1200,0&ssl=1&description=BioNTech+Stock+Drops+as+Sales+Outlook+Disappoints+%7C+Global+News+Avenue){kind=link}